Jamie L. Reynoso - Mar 14, 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO, Medicare Advantage
Signature: /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso
Stock symbol: CLOV
Transactions as of: Mar 14, 2024
Transactions value $: -$5,677
Form type: 4
Date filed: 3/18/2024, 04:33 PM
Previous filing: Jan 9, 2024
Next filing: Mar 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Tax liability	-$5.68K	-7.78K	-0.31%	$0.73	2.48M	Mar 14, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.